Jeff Bezos’ Blue Origin Raised $10 Billion at a $130 Billion Valuation
Key Points When founders put significant personal money into a funding round alongside new investors, it’s often a sign they’re…
The Archive
Every market briefing, in one place.
In-depth analysis on the Fed, earnings, labor, commodities, and the news that moves markets. Filter by topic to find what you’re looking for.
The Average TFSA Balance for Canadians at 55
Turning 55 changes how people think about money, given that retirement is on the horizon. It is also the point…
An Astera Labs Insider Sold at $458, but the 93% Revenue Growth Is the Real Story
Key Points This sale involved 8,491 shares valued at $3.9 million based on the weighted average execution price on July…
South Korea Shares May Extend Winning Streak
(RTTNews) – The South Korea stock market has moved higher in seven straight sessions, collecting more than 115 points or…
Japan Shares Poised To Open To The Upside On Monday
(RTTNews) – The Japan stock market has tracked higher in consecutive trading days, advancing almost 1,750 points or 2.6 precent…
What This Invesco Insider Move Signals With the Stock Up 63%
Key Points The transaction involved 26,002 shares withheld to satisfy tax obligations at a value of $702,000 based on the…
Top Value Investor Bill Miller IV Says Bitcoin Is Undervalued. So How Much Higher Can Bitcoin Go This Year?
Key Points Bitcoin is now 50% off its all-time high, leading many to question whether it has any intrinsic value.…
Best Artificial Intelligence (AI) Stock: AMD, Nvidia, or Broadcom
Key Points If you asked me at the start of the year how I would rank Advanced Micro Devices (NASDAQ:…
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Vertex Pharmaceuticals (NASDAQ:VRTX) said it has entered into a definitive agreement to acquire Crinetics Pharmaceuticals for $85 per share in…